0001209191-21-038279.txt : 20210604
0001209191-21-038279.hdr.sgml : 20210604
20210604164431
ACCESSION NUMBER: 0001209191-21-038279
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210602
FILED AS OF DATE: 20210604
DATE AS OF CHANGE: 20210604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xilas Andrew
CENTRAL INDEX KEY: 0001863490
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38848
FILM NUMBER: 21997059
MAIL ADDRESS:
STREET 1: 5960 HEISLEY ROAD
CITY: MENTOR
STATE: OH
ZIP: 44060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STERIS plc
CENTRAL INDEX KEY: 0001757898
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 70 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 35312322000
MAIL ADDRESS:
STREET 1: 70 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: STERIS Ltd
DATE OF NAME CHANGE: 20181101
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-02
0
0001757898
STERIS plc
STE
0001863490
Xilas Andrew
C/O 70 SIR JOHN ROGERSON'S QUAY
DUBLIN
L2
2
IRELAND
0
1
0
0
SVP and GM, Dental
Ordinary Shares
2021-06-02
4
A
0
232
A
232
D
Restricted Stock Units
2021-06-02
4
A
0
619
A
Ordinary Shares
619
619
D
Restricted Stock Units
2021-06-02
4
A
0
277
A
Ordinary Shares
277
976
D
Restricted Stock Units
2021-06-02
4
A
0
1445
A
Ordinary Shares
1445
2421
D
Restricted Stock Units
2021-06-02
4
A
0
999
A
Ordinary Shares
999
3420
D
Restricted Stock Units
2021-06-02
4
A
0
113
A
Ordinary Shares
113
3533
D
Restricted Stock Units
2021-06-02
4
A
0
373
A
Ordinary Shares
373
3906
D
Received in exchange for 687 shares of Cantel Medical Corp. ("Cantel") common stock in connection with the acquisition of Cantel by STERIS plc ("STERIS") pursuant to a series of transactions (the "Mergers"). Holders of Cantel common stock received $16.93 in cash and 0.33787 STERIS ordinary shares ("Ordinary Shares") per Cantel share outstanding immediately prior to the Mergers.
Reflects 619 restricted stock units ("RSUs") of STERIS. Each STERIS RSU represents a right to receive one Ordinary Share. These STERIS RSUs were received in exchange for 1,453 RSUs of Cantel in connection with the Mergers based on an exchange ratio of 0.4262 STERIS RSUs for every Cantel RSU outstanding immediately prior to the Mergers, with the number of resulting STERIS RSUs rounded to the nearest whole unit. These RSUs are restricted and vest in two equal installments on 10/10/2021 and 10/10/2022.
Reflects 277 STERIS RSUs. Each STERIS RSU represents a right to receive one Ordinary Share. These STERIS RSUs were received in exchange for 650 Cantel RSUs in connection with the Mergers based on an exchange ratio of 0.4262 STERIS RSUs for every Cantel RSU outstanding immediately prior to the Mergers, with the number of resulting STERIS RSUs rounded to the nearest whole unit. These RSUs are restricted and vest in two equal installments on 10/10/2021 and 10/10/2022.
Reflects 1,445 STERIS RSUs. Each STERIS RSU represents a right to receive one Ordinary Share. These STERIS RSUs were received in exchange for 3,390 Cantel RSUs in connection with the Mergers based on an exchange ratio of 0.4262 STERIS RSUs for every Cantel RSU outstanding immediately prior to the Mergers, with the number of resulting STERIS RSUs rounded to the nearest whole unit. These RSUs are restricted and vest in three equal installments on 10/7/2021, 10/7/2022 and 10/7/2023.
Reflects 999 STERIS RSUs. Each STERIS RSU represents a right to receive one Ordinary Share. These STERIS RSUs were received in exchange for 2,345 Cantel RSUs in connection with the Mergers based on an exchange ratio of 0.4262 STERIS RSUs for every Cantel RSU outstanding immediately prior to the Mergers, with the number of resulting STERIS RSUs rounded to the nearest whole unit. These RSUs are restricted and vest in three equal installments on 12/2/2021, 12/2/2022 and 12/2/2023.
Reflects 113 STERIS RSUs. Each STERIS RSU represents a right to receive one Ordinary Share. These STERIS RSUs were received in exchange for 265 performance-based restricted stock units ("PSUs") of Cantel in connection with the Mergers based on an exchange ratio of 0.4262 STERIS RSUs for every Cantel PSU outstanding immediately prior to the Mergers, with the number of resulting STERIS RSUs rounded to the nearest whole unit. These RSUs are restricted and vest in equal installments on 10/10/2021 and 10/10/2022.
Reflects 373 STERIS RSUs. Each STERIS RSU represents a right to receive one Ordinary Share. These STERIS RSUs were received in exchange for 875 Cantel PSUs in connection with the Mergers based on an exchange ratio of 0.4262 STERIS RSUs for every Cantel PSU outstanding immediately prior to the Mergers, with the number of resulting STERIS RSUs rounded to the nearest whole unit. These RSUs are restricted and vest in equal installments on 10/7/2021, 10/7/2022 and 10/7/2023.
The STERIS RSUs will vest as follows: 607 on October 7, 2021, 506 on October 10, 2021, 333 on December 2, 2021, 606 on October 7, 2022, 503 on October 10, 2022, 333 on December 2, 2022, 605 on October 7, 2023 and 333 on December 2, 2023.
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
2021-06-04